The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 157.50
Bid: 150.00
Ask: 165.00
Change: 0.00 (0.00%)
Spread: 15.00 (10.00%)
Open: 157.50
High: 157.50
Low: 157.50
Prev. Close: 157.50
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

8 Jun 2021 07:00

RNS Number : 0888B
Itaconix PLC
08 June 2021
 

For release: 8 June 2021

 

Itaconix plc

 

("Itaconix" or "the Company")

 

Trading Update

 

Itaconix plc (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used as essential ingredients in everyday consumer products, is pleased to provide an update on its commercial progress and current trading.

 

Strong revenue growth in odour control, continued growth in detergents, and a small decline in personal care combined for overall unaudited revenues to increase by 39% for the first five months of 2021 over the same period in 2020.

 

Product volumes in odour control applications are leading revenue growth in early 2021 based on several years of customer pipeline development and the emerging success of our latest odour control polymer launched in late 2019. Recurring orders are coming in North America, Europe, and Asia from the continued success of customer products. Advantages in fabric applications are also generating new orders from wider use in home and automotive care. The Company is working to expand its odour control offerings and applications to meet additional market needs.

 

Product volumes in detergent applications increased for the first five months of 2021 over the same period in 2020 despite order delays in North America from disruptions in the supply of other detergent ingredients. Brands and retailers are also adjusting inventories due to uncertainties about consumer buying as countries emerge from Covid-19 lockdowns. Highlights for the current year include the launch of a new green dishwashing detergent by a leading North American brand, wider market penetration into North American retailers for detergents launched in 2020, growth in volumes for a green European detergent launched in 2019, and the first production run for a specialty European detergent brand. At least three additional detergent brands are expected to start using Itaconix® TSI™ by the end of 2021. Although the Company is seeing renewed evaluation activity as formulators return to work, the Board expects some continued delays in volumes for detergent applications as supply chains adjust to the end of lockdowns.

 

Revenues in personal care applications for the first five months of 2021 were slightly less than the same period in 2020 as shipments in the last part of 2020 met customer needs during the lockdowns in North America and Europe. The Board expects there may be a period of variable order patterns as formulators return to work and consumers return to more normal buying behaviours as they emerge from the Covid-19 pandemic.

 

As previously announced, the expansion of the Itaconix management team has enabled increased focus on new revenue opportunities. The Company plans to extend the use of its VELAFRESH™ products into new hygiene opportunities and expand the potential for its VELASOFT™ product line into personal care applications.

Applications development also continues for BIO*Asterix™ functional additives, with extended customer formulation timelines likely for the types of applications under evaluation.

 

The Company's balance sheet will also be strengthened following notification that the US Small Business Administration intends to forgive the $0.2m loan that Itaconix received last year under the US Government Paycheck Protection Program, which will eliminate this liability.

 

Itaconix recently received the London Stock Exchange's Green Economy Mark in recognition for the Company's significant contributions to the transition to a sustainable, low carbon economy. Itaconix generated 96% of its 2020 revenues from the sale of plant-based products. The Mark, first introduced in 2019, was created to highlight companies and investment funds listed on all segments of the London Stock Exchange's Main Market, and on AIM, that are driving the global green economy.

 

John R. Shaw, CEO of Itaconix, said:

 

"Our focus on being key ingredients in everyday consumer products is delivering continued commercial progress on the revenue potential in every household for our plant-based technologies. As we increase recognition of the Company's green credentials, improve our balance sheet, and expand our line of sustainable products, we are positioning Itaconix for new routes to broader revenue horizons in the emerging low-carbon economy."  

 

- ends -

 

Enquiries:

 

Itaconix

+1 (603) 775 4400

John R. Shaw / Laura Denner

 

Belvedere Communications

+44 (0) 20 3687 2756

John West / Llew Angus

N+1 Singer

+44 (0) 207 496 3000

Peter Steel / James Moat (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

 

This announcement contains information which, prior to its disclosure, was inside information as stipulated under the UK version of article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

Notes to Editors

 

Itaconix develops and produces bio-based specialty polymers that improve the safety, performance and sustainability of consumer and industrial products, with technology and market leading positions in non-phosphate detergents, odour control, and hair styling.

www.itaconix.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRGDLSDGDGBR
Date   Source Headline
29th Apr 20247:00 amRNSLaunch of two plant-based performance ingredients
19th Apr 20247:00 amRNSGrants of Options & PDMR dealings
15th Apr 20247:00 amRNSPreliminary Results and Notice of AGM
8th Apr 20247:00 amRNSNotice of Results
2nd Apr 20247:00 amRNSTrading Statement
27th Feb 20247:00 amRNSTrading Update
9th Feb 20247:00 amRNSAppointment of Non-Executive Director
26th Jan 20247:00 amRNSAppointment: Nominated Adviser and Sole Broker
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
30th Oct 20237:00 amRNSDirector/PDMR Shareholding
26th Oct 20235:28 pmRNSDirector/PDMR Shareholding
19th Oct 20235:08 pmRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSDirector/PDMR Shareholding
5th Oct 202311:01 amRNSHoldings in Company
12th Sep 20237:00 amRNSHalf year results
5th Sep 20237:00 amRNSNotice of Interim Results and Presentations
22nd Aug 20237:00 amRNSShare Consolidation & Total Voting Rights
15th Aug 20237:00 amRNSShare Consolidation
12th Jul 20237:00 amRNSTrading Update
28th Jun 202312:29 pmRNSAGM Statement
5th Jun 20237:00 amRNSFinal Results
24th May 20237:00 amRNSNotice of Final Results, Briefings, and AGM
25th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
2nd Mar 20233:25 pmRNSTR-1
1st Mar 20237:00 amRNSAward from Frost & Sullivan
28th Feb 20236:03 pmRNSTR-1
28th Feb 20235:04 pmRNSTR-1
28th Feb 20233:09 pmRNSTR-1
23rd Feb 20237:00 amRNSTR-1
22nd Feb 202312:28 pmRNSResults of Open Offer, GM and Total Voting Rights
15th Feb 20237:00 amRNSInvestor Presentation following GM on 22 Feb 2023
3rd Feb 20237:00 amRNSPlacing, Subscription and Open Offer; Notice of GM
5th Jan 20237:00 amRNSBoard Change
6th Dec 20224:40 pmRNSSecond Price Monitoring Extn
6th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Oct 20227:00 amRNSItaconix and Brenntag Promote Sustainable Cleaning
14th Sep 20227:00 amRNSHalf year results
13th Sep 202211:05 amRNSSecond Price Monitoring Extn
13th Sep 202211:00 amRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSNotice of Results
5th Sep 20227:00 amRNSItaconix and Croda Renew Supply Agreement
20th Jul 20227:00 amRNSBoard Change
13th Jul 20227:00 amRNSTrading Update
5th Jul 20227:00 amRNSDirectorate Change
1st Jul 20222:37 pmRNSResult of AGM
1st Jul 20229:00 amRNSPrice Monitoring Extension
1st Jul 20227:00 amRNSAGM Statement and Notice of Capital Markets Event
29th Jun 20227:00 amRNSNotice of Capital Markets Webinar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.